Exploring Shigella vaccine priorities and preferences: Results from a mixed-methods study in low- and middle-income settings
Background: Shigella is the leading bacterial cause of diarrheal mortality in children and can cause long-term effects on growth and development. No licensed Shigella vaccines currently exist but several promising candidates are in development and could be available in the next five years. Despite S...
Main Authors: | Jessica A. Fleming, Nikki Gurley, Sophia Knudson, Lassane Kabore, John Tanko Bawa, Patience Dapaah, Sandeep Kumar, Surendra Uranw, Thang Tran, Le Thi Phuong Mai, Chris Odero, Christopher Obong'o, Kofi Aburam, Stella Wanjiru, Nguyen Thi My Hanh, Luu Phuong Dung, William P. Hausdorff |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Vaccine: X |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2590136223001092 |
Similar Items
-
Assembly, Biochemical Characterization, Immunogenicity, Adjuvanticity, and Efficacy of <italic toggle="yes">Shigella</italic> Artificial Invaplex
by: K. Ross Turbyfill, et al.
Published: (2018-04-01) -
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
by: Kawsar R. Talaat, et al.
Published: (2021-04-01) -
Immunization of Rabbits with a Quadrivalent Shigella Bioconjugate Vaccine Induces Functional Antibodies Reactive with Shigella Isolates from Kenya
by: Elizabeth A. Odundo, et al.
Published: (2022-06-01) -
Development of the Shigella flexneri 2a, 3a, 6, and S. sonnei artificial Invaplex (InvaplexAR) vaccines
by: K. Ross Turbyfill, et al.
Published: (2023-08-01) -
The <i>Shigella</i> Vaccines Pipeline
by: Calman Alexander MacLennan, et al.
Published: (2022-08-01)